CUSIP: 68230A106
Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,238,087
-
Share change
-
-931,346
-
Total reported value
-
$1,165,240
-
Price per share
-
$0.36
-
Number of holders
-
21
-
Value change
-
-$414,604
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) as of Q2 2017
As of 30 Jun 2017,
ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,238,087 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Virtu KCG Holdings LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, NORTHERN TRUST CORP, Bank of New York Mellon Corp, CITADEL ADVISORS LLC, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.